COVID-19 Spain - Volunteering for good causes in Spain
Three Boehringer Ingelheim employees in Spain have stepped forward to help out during the COVID-19 pandemic. Click here to find out and learn more.
Search
COVID-19 Relief Efforts in China
Since the outbreak of the Coronavirus disease in China in late January, Boehringer Ingelheim has quickly decided to make a number of donations. Read more.
COVID-19 Emotional support for physicians in Mexico
As part of the efforts to help different sectors, Boehringer Ingelheim México created the Emotional Containment Program for Health Care Professionals.
COVID-19 Southeast Asia Support of Healtvare Community
Learn more about what Boehringer Ingelheim is doing to assist health workers in managing the pandemic in Southeast Asia. Click here to find out more.
1885-1948
In 1885, Albert Boehringer purchased a small tartar factory in the Rhine-Hessian village of Nieder-Ingelheim. Click here to learn more about our history.
The METAmorphosis
At Boehringer Ingelheim’s META offices in the Middle East, Turkey and Africa all offices in the region are already free of single-use plastic. Learn more.
Waste
Resource conservation at Boehringer Ingelheim is managed as part of an ongoing process of prevention and reduction of material usage and waste. Learn more.
REACH / GHS / Material safety data sheets
European and international chemical legislations like REACH and GHS impact Boehringer Ingelheim's activities in many different ways. Learn more here.
Circular economy towards the future
Boehringer Ingelheim uses eco-design to shape and develop animal health products with an improved environmental profile. Click here to read more.
Our-position
12 years ago, several leading German companies including Boehringer Ingelheim came together to launch Afrika Kommt! Learn more about it here.
History
Learn about the history of Boehringer Ingelheim, starting with Albert Boehringer founding the company in 1885 when it employed just 28 people.
COVID-19: Research Update
Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
Women in STEM 2022
Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM. Click here to find out more.
Be Green Brazil – powered by nature
At Boehringer Ingelheim’s Solana farm Adrian von Treuenfels and his team cultivate the plants that supply the active ingredient for different drugs.
The Nagoya Protocol
At Boehringer Ingelheim, environmental consciousness and protection are priorities in everything we do. Read our commitments to the Nagoya Protocol.
Our Employees
We offer our employees demanding and challenging tasks. Boehringer Ingelheim needs employees who innovate. Learn more about our employees here.
FuturePack
Boehringer Ingelheim has built a new special machine that enables efficient and sustainable packaging of small batches. Learn more about this here.
Be green Japan
Boehringer Ingelheim's Yamagata site is gradually switching to a more sustainable energy supply. Click here to find out more information about this.
Bees and biodiversity
At Boehringer Ingelheim we attach great importance to sustainable planting on our company site – and to protecting the bees. Click here to find out more.
The power of our people
Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity; a key element of our culture. Click here to find out more information.
COVID-19 Germany Together through the Pandemic
Boehringer Ingelheim enabled all 51,000 employees worldwide to take ten days off for voluntary work – with full payment. Click here to learn more.
Contact Us
To contact us at Boehringer Ingelheim click here to find our contact details and information, including our address, emails, and phone numbers.
Press Kit Animal Health
This press kit page comprises of downloads available for journalists looking for the latest information about the Boehringer Ingelheim Animal Health.
Speak up
We are committed to conducting business with integrity and in compliance with applicable laws, regulations, company policies and procedures. Find out more.
Improving Access to Stroke Care
Boehringer Ingelheim’s Angels Initiative is featured as a Best Practice example by the Access to Medicine Initiative. Click here to find out more.